Chimerix: Big News, Big Moves, So Maybe Now's The Time To Buy

When I first took a look at Chimerix, Inc. (NASDAQ: CMRX ) back in March 2024 , I expressed substantial optimism for the investment thesis at the price theI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of investing in this space.Analyst’s Disclosure: I/we have no ...